(2S,4R)-1-Boc-4-(叔丁基二甲基硅氧基)-2-(羟甲基)吡咯烷, ≥98%,(2S,4R)-1-Boc-4-(tert-butyldimethylsilyloxy)-2-(hydroxymethyl)pyrrolidine
产品编号：西域试剂-WR377214| CAS NO：114676-67-4| MDL NO：MFCD01862190| 分子式：C16H33NO4Si| 分子量：331.52
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，
| 英文名称 | (2S,4R)-1-Boc-4-(tert-butyldimethylsilyloxy)-2-(hydroxymethyl)pyrrolidine |
|---|---|
| CAS编号 | 114676-67-4 |
| 精确质量 | 331.21800 |
| PSA | 59.00000 |
| LogP | 3.31640 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
|
~95%
114676-67-4 |
| 文献：Elsohly, Adel M.; Wespe, Daniel A.; Poore, Tyler J.; Snyder, Scott A. Angewandte Chemie - International Edition, 2013 , vol. 52, # 22 p. 5789 - 5794 Angew. Chem., 2013 , vol. 125, # 22 p. 5901 - 5906,7 |
|
~93%
114676-67-4 |
| 文献：APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. Patent: WO2004/76407 A2, 2004 ; Location in patent: Page 27-29 ; WO 2004/076407 A2 |
|
~%
114676-67-4 |
| 文献：Fujisawa Pharmaceutical Co., Ltd. Patent: US4822787 A1, 1989 ; |
|
~%
114676-67-4 |
| 文献：ROTTAPHARM S.P.A.; STASI, Luigi, Piero; ROVATI, Lucio Patent: WO2011/6960 A1, 2011 ; WO 2011/006960 A1 |
|
~%
114676-67-4 |
| 文献：ROTTAPHARM S.P.A.; STASI, Luigi, Piero; ROVATI, Lucio Patent: WO2011/6960 A1, 2011 ; WO 2011/006960 A1 |
|
~%
114676-67-4 |
| 文献：Fransson, Rebecca; McCracken, Alison N.; Chen, Bin; McMonigle, Ryan J.; Edinger, Aimee L.; Hanessian, Stephen ACS Medicinal Chemistry Letters, 2013 , vol. 4, # 10 p. 969 - 973 |
|
~%
114676-67-4 |
| 文献：Zheng, Bo; Wang, Hui; Han, Yong; Liu, Changlu; Peng, Yungui Chemical Communications, 2013 , vol. 49, # 40 p. 4561 - 4563 |
|
~%
114676-67-4 |
| 文献：Zheng, Bo; Wang, Hui; Han, Yong; Liu, Changlu; Peng, Yungui Chemical Communications, 2013 , vol. 49, # 40 p. 4561 - 4563 |
|
~%
114676-67-4 |
| 文献：Elsohly, Adel M.; Wespe, Daniel A.; Poore, Tyler J.; Snyder, Scott A. Angewandte Chemie - International Edition, 2013 , vol. 52, # 22 p. 5789 - 5794 Angew. Chem., 2013 , vol. 125, # 22 p. 5901 - 5906,7 |
| 上游产品 8 | |
|---|---|
| 下游产品 1 | |
浙公网安备 33010802013016号